Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Electromagn Biol Med ; 34(2): 106-12, 2015.
Article in English | MEDLINE | ID: mdl-26098521

ABSTRACT

The experimental conditions by which electromagnetic signals (EMS) of low frequency can be emitted by diluted aqueous solutions of some bacterial and viral DNAs are described. That the recorded EMS and nanostructures induced in water carry the DNA information (sequence) is shown by retrieval of that same DNA by classical PCR amplification using the TAQ polymerase, including both primers and nucleotides. Moreover, such a transduction process has also been observed in living human cells exposed to EMS irradiation. These experiments suggest that coherent long-range molecular interaction must be present in water to observe the above-mentioned features. The quantum field theory analysis of the phenomenon is presented in this article.


Subject(s)
DNA/metabolism , Electromagnetic Radiation , Water/metabolism , Cell Survival , Humans , Models, Biological
2.
J Transl Med ; 10: 22, 2012 Feb 06.
Article in English | MEDLINE | ID: mdl-22309994

ABSTRACT

BACKGROUND: A mobile health unit may be useful to follow up adult and pediatric patients on antiretroviral treatment and living in remote areas devoid of laboratory facilities. The study evaluated the use of the simplified, robust, single-plateform, volumetric, pan-leucogating Auto40 flow cytometer (Apogee Flow Systems Ltd, Hemel Hempstead, UK) for CD4 T cell numeration in a mobile unit, compared against a reference flow cytometry method. METHODS: The therapeutic mobile unit of the Laboratoire National de Santé Hygiène Mobile, Yaoundé, Cameroon, was equipped with the Auto40. A FACSCalibur flow cytometer (Becton Dickinson Immuno-cytometry System, San Jose, CA, USA) was used as reference method. EDTA-blood samples from volunteers were first subjected to CD4 T cell count in the mobile unit, and an aliquot was sent within 4 hours to Centre International de Référence Chantal Biya, Yaoundé, for FACSCalibur assay. RESULTS: Two HIV screening campaigns with the mobile unit were organised in December 2009 and January 2010. The campaign in the suburb of Yaoundé which was 20 km from the reference laboratory included 188 volunteers comprising 93 children less than 5 years old. The campaign in Ambang Bikok (53 km far from Yaoundé) included 69 adult volunteers. In Yaoundé suburb, mean ± standard deviation (SD) CD4 T cell count was 996 ± 874 cells/µl by Auto40, and 989 ± 883 cells/µl by FACSCalibur; in Ambang Bikok, mean ± SD CD4 T cell count was 1041 ± 317 cells/µl by Auto40, and 1032 ± 294 cells/µl by FACSCalibur. Results by Auto40 and FACSCalibur were highly correlated in Yaoundé (r(2) = 0.982) as in Ambang Bikok (r(2) = 0.921). Bland-Altman analysis showed a close agreement between Auto40 and FACSCalibur results expressed in absolute count as in percentage in Yaoundé and Ambang Bikok. When pooling the 257 CD4 T cell count measurements, the Auto40 yielded a mean difference of +7.6 CD4 T cells/µl higher than by reference flow cytometry; and the sensitivity and specificity of Auto40 in enumerating absolute CD4 T cell counts of less than 200 cells/µl were 87% and 99%, respectively, and in enumerating absolute CD4 T cell counts of less than 350 cells/µl were 87% and 98%, respectively. The intrarun and interun precisions of the Auto40 assay assessed in the mobile unit were 5.5% and 7.9%, respectively. CONCLUSIONS: The Auto40 flow cytometer installed in a therapeutic mobile unit and operated far from its reference laboratory gave a perfect correlation with the reference method, and could be useful in carrying out immunological monitoring of HIV-infected patients living in areas without access to laboratory facilities.


Subject(s)
CD4 Lymphocyte Count/instrumentation , CD4 Lymphocyte Count/methods , Flow Cytometry/instrumentation , Flow Cytometry/methods , Mobile Health Units , Adult , Cameroon , Child, Preschool , Edetic Acid , Female , Humans , Male , Rural Population , Sensitivity and Specificity
3.
IAVI Rep ; 15(3): 13-4, 2011.
Article in English | MEDLINE | ID: mdl-21809800
4.
Toxicology ; 278(1): 6-16, 2010 Nov 28.
Article in English | MEDLINE | ID: mdl-20870007

ABSTRACT

Fermented papaya preparation (FPP) (a product of yeast fermentation of Carica papaya Linn) is a food supplement. Studies in chronic and degenerative disease conditions (such as thalassemia, cirrhosis, diabetes and aging) and performance sports show that FPP favorably modulates immunological, hematological, inflammatory, vascular and oxidative stress damage parameters. Neuroprotective potential evaluated in an Alzheimer's disease cell model showed that the toxicity of the ß-amyloid can be significantly modulated by FPP. Oxidative stress trigger apoptotic pathways such as the c-jun N-terminal kinase (JNK) and p38-mitogen activated protein kinase (MAPK) are preferentially activated by pro-inflammatory cytokines and oxidative stress resulting in cell differentiation and apoptosis. FPP modulated the H2O2-induced ERK, Akt and p38 activation with the reduction of p38 phosphorylation induced by H2O2. FPP reduces the extent of the H2O2-induced DNA damage, an outcome corroborated by similar effects obtained in the benzo[a]pyrene treated cells. No genotoxic effect was observed in experiments with FPP exposed to HepG2 cells nor was FPP toxic to the PC12 cells. Oxidative stress-induced cell damage and inflammation are implicated in a variety of cancers, diabetes, arthritis, cardiovascular dysfunctions, neurodegenerative disorders (such as stroke, Alzheimer's disease, and Parkinson's disease), exercise physiology (including performance sports) and aging. These conditions could potentially benefit from functional nutraceutical/food supplements (as illustrated here with fermented papaya preparation) exhibiting anti-inflammatory, antioxidant, immunostimulatory (at the level of the mucus membrane) and induction of antioxidant enzymes.


Subject(s)
Carica/chemistry , Dietary Supplements , Plant Preparations/administration & dosage , Alzheimer Disease/diet therapy , Alzheimer Disease/metabolism , Anemia/diet therapy , Anemia/metabolism , Animals , Carica/metabolism , Diabetes Mellitus/diet therapy , Diabetes Mellitus/metabolism , Fermentation , Humans , Inflammation/diet therapy , Inflammation/metabolism , Oxidative Stress/drug effects , Plant Preparations/chemistry , Sports/physiology
8.
Interdiscip Sci ; 1(4): 245-53, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20640802

ABSTRACT

Electromagnetic signals of low frequency have been shown to be durably produced in aqueous dilutions of the Human Imunodeficiency Virus DNA. In vivo, HIV DNA signals are detected only in patients previously treated by antiretroviral therapy and having no detectable viral RNA copies in their blood. We suggest that the treatment of AIDS patients pushes the virus towards a new mode of replication implying only DNA, thus forming a reservoir insensitive to retroviral inhibitors. Implications for new approaches aimed at eradicating HIV infection are discussed.


Subject(s)
Acquired Immunodeficiency Syndrome/blood , Acquired Immunodeficiency Syndrome/drug therapy , Anti-Retroviral Agents/therapeutic use , DNA, Viral/genetics , Electromagnetic Phenomena , HIV/genetics , RNA, Viral/genetics , Algorithms , Biophysics/methods , Computational Biology/methods , Computer Simulation , Erythrocytes/virology , Humans , Models, Theoretical , Polymerase Chain Reaction
9.
Interdiscip Sci ; 1(2): 81-90, 2009 Jun.
Article in English | MEDLINE | ID: mdl-20640822

ABSTRACT

A novel property of DNA is described: the capacity of some bacterial DNA sequences to induce electromagnetic waves at high aqueous dilutions. It appears to be a resonance phenomenon triggered by the ambient electromagnetic background of very low frequency waves. The genomic DNA of most pathogenic bacteria contains sequences which are able to generate such signals. This opens the way to the development of highly sensitive detection system for chronic bacterial infections in human and animal diseases.


Subject(s)
DNA, Bacterial/metabolism , Electromagnetic Phenomena , Nanostructures/chemistry , Animals , Bacterial Infections/etiology , Computer Systems , Filtration , Humans , Models, Biological , Mycoplasma/metabolism , Water/chemistry , Water Pollutants , Water Purification/methods
10.
Biochem Pharmacol ; 74(6): 898-910, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17662695

ABSTRACT

In this study, we demonstrated the efficiency and feasibility of a gene therapy protocol against HIV infection using the antiviral effects of IFN-beta expression. Lentiviral vectors containing the human or the simian IFN-beta sequences under the influence of the murine moderate H2-kb promoter were constructed. To examine the capacity of IFN-beta to inhibit the replication of HIV in human CD4(+) cells, a transduction protocol permitting to efficiently transduce CD4(+) cells or PBMC (85+/-12% of CD4(+)-transduced cells) with a moderate expression of IFN-beta was developed. Results indicate that enforced expression of IFN-beta has no negative effects in terms of apoptosis and proliferation. In human CD4(+) cells, it drastically inhibits (up to 99.9%) replication after challenging with different strains of HIV-1. The expression of exogenous IFN-beta leads to an amplification of the CD4(+) cells (11-fold) and to a drastic decrease of the p24 protein. Micro-array analyses indicated that antiviral effect of IFN-beta could be due to a major regulation of the inflammatory response. These results are encouraging for the development of a clinical study of gene therapy against AIDS using IFN-beta.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Genetic Therapy/methods , HIV Infections/therapy , HIV-1/drug effects , Interferon-beta/administration & dosage , Virus Replication/drug effects , Animals , Antiviral Agents/administration & dosage , Antiviral Agents/pharmacology , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/transplantation , Cell Proliferation/drug effects , Genetic Vectors , Haplorhini , Humans , Inflammation/drug therapy , Interferon-beta/pharmacology , Mice , Transduction, Genetic
16.
J Acquir Immune Defic Syndr ; 29(2): 149-57, 2002 Feb 01.
Article in English | MEDLINE | ID: mdl-11832684

ABSTRACT

OBJECTIVE: To describe the clinical and biologic evolution of HIV-1 infection in Africa. METHODS: One hundred four HIV-1-infected individuals were identified prospectively from regular blood donors in Abidjan, Côte d'Ivoire. The date of seroconversion was estimated from results of sequential serologic tests. Biologic and clinical follow-up was performed every 6 months, starting as early as possible after seroconversion. Case management followed national guidelines. RESULTS: The median interval between estimated seroconversion and study inclusion was 9.7 months, and the median window of seroconversion was 2.8 months. At baseline, all but two patients were asymptomatic; the median CD4 + cell count was 527/mm 3 (interquartile range [IR], 395-684), and the median plasma HIV RNA level was 4.6 log 10 copies/ml (IR, 3.8-4.9). The median follow-up was 23.9 months, and 95% of the patients received primary prophylaxis with co-trimoxazole for opportunistic infections. Of the patients, 1 presented with wasting syndrome, 3 developed tuberculosis, and 17 had a Centers for Disease Control and Prevention category B-defining event. The 3-year AIDS-free and symptom-free probabilities were 96.7% (95% confidence interval [CI], 87.0-99.2] and 79.3% (95% CI, 67.5-87.2), respectively. During the first 3 years of follow-up, we observed that the median plasma viral load stabilized at >4 log 10 copies/ml and that the median CD4 + cell count declined by 20 to 25/mm 3 per year. CONCLUSION: These African seroconverters were moderately immunosuppressed. The median HIV RNA level was high and varied very little during the first 3 years, and there were few clinical events.


Subject(s)
Evolution, Molecular , HIV Seropositivity/virology , HIV-1 , Adult , CD4 Lymphocyte Count , Cote d'Ivoire , Female , Follow-Up Studies , Genes, env , HIV Protease/genetics , HIV Reverse Transcriptase/genetics , HIV Seropositivity/complications , HIV Seropositivity/epidemiology , HIV Seropositivity/immunology , HIV-1/genetics , HIV-1/immunology , Humans , Male , Middle Aged , Prospective Studies , RNA, Viral/blood , Risk Factors , Surveys and Questionnaires , Tuberculosis, Pulmonary/complications , Viral Load
17.
Mol Immunol ; 38(8): 607-18, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11792429

ABSTRACT

We have characterized the humoral and cellular immune responses of BALB/c mice immunized with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) PLG particles. Three groups of mice were immunized with Nef PLG, Nef in the presence of complete Freund's adjuvant (CFA) or Nef alone in PBS. When titers were compared 7 months after the last injection, anti-Nef titers in mice immunized with Nef PLG were still close to the maximum, whereas a significant decrease was observed in mice immunized with Nef alone (five times lower) or with Nef in CFA (three times lower). These results indicate that Nef PLG is at least a similar or better vector/adjuvant than Nef in CFA concerning the duration of the humoral immune response. The analysis of cytokine profiles (IL-5 and IL-10) and the isotypic patterns of anti-Nef antibodies (predominantly IgG1), in the three groups of mice, indicated a predominant Th2 immune response. Using synthetic peptides covering the entire sequence of Nef, we identified at least three linear epitopes within sequences 32-64, 118-167 and 185-205 in the sera of mice immunized with Nef PLG or Nef CFA. In contrast, anti-Nef antibodies against Nef alone failed to recognize synthetic peptides, indicating that the majority of anti-Nef antibodies were primarily directed against conformational epitopes. We then examined the ability of Nef PLG to prime for the antigen-specific proliferative responses in vitro. The data obtained indicate the presence of both B-cell and T-cell epitopes in the C-terminal fragment of the protein after immunization of mice with Nef encapsulated in PLG particles.


Subject(s)
Gene Products, nef/immunology , HIV Antibodies/biosynthesis , HIV Antigens/immunology , HIV-1/immunology , Lactic Acid/administration & dosage , Polyglycolic Acid/administration & dosage , Polymers/administration & dosage , Animals , Cells, Cultured , Cytokines/biosynthesis , Epitopes, B-Lymphocyte/immunology , Female , Freund's Adjuvant/pharmacology , Gene Products, nef/administration & dosage , HIV Antigens/administration & dosage , Immunization , Immunoglobulin G/biosynthesis , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Microspheres , Polylactic Acid-Polyglycolic Acid Copolymer , Spleen/immunology , T-Lymphocytes/immunology , nef Gene Products, Human Immunodeficiency Virus
18.
Microbiology (Reading) ; 144 ( Pt 5): 1247-1255, 1998 May.
Article in English | MEDLINE | ID: mdl-9611799

ABSTRACT

Among the wall-less mycoplasmas only a few species have been identified with a capsule at their cell surface. Mycoplasma penetrans is a recently identified mycoplasma with unique morphology, isolated from HIV-infected patients. Using transmission electron microscopy, it was found that M. penetrans is surrounded by capsular material 11 nm (strain GTU-54-6A1) to 30 nm (strain HF-2) thick, which can be stained with ruthenium red and labelled with cationized ferritin. The polysaccharide composition of this capsule was indicated by its staining with periodic acid-thiocarbohydrazide silver proteinate and the abolition of ruthenium red staining of the cell surface by neuraminidase treatment. In addition, proteinase K treatment of the M. penetrans cells resulted in removal of the capsule, suggesting that polypeptides may contribute in anchoring it to the membrane or in its stability. Two different types of glycosylated material were detected in mycoplasma extracts by SDS-PAGE and periodic acid-Schiff staining. The first component was a high-molecular-mass material, which was heat- and proteinase-K-labile and which probably constitutes the capsular polymer. The other component was a low-molecular-mass glycolipid fraction, which was proteinase-K-, heat- and EDTA-resistant. The identification of a capsule at the M. penetrans cell surface is of particular interest for a mycoplasma which has been shown to adhere to various host cells and to penetrate into their intracellular compartments. The capsule may have significance in the pathogenesis of disease associated with infection by this organism.


Subject(s)
Bacterial Capsules/analysis , Glycolipids/analysis , Mycoplasma penetrans/chemistry , Mycoplasma penetrans/ultrastructure , Bacterial Capsules/chemistry , Bacterial Capsules/ultrastructure , Coloring Agents , Electrophoresis, Polyacrylamide Gel , Endopeptidase K/metabolism , Ferritins , Glycoconjugates/analysis , Humans , Microscopy, Electron , Mycoplasma penetrans/enzymology , Mycoplasma penetrans/growth & development , Periodic Acid-Schiff Reaction , Ruthenium Red
19.
Rio de Janeiro; Jorge Zahar; 1995. 239 p.
Monography in Portuguese | LILACS | ID: lil-166553

ABSTRACT

Aborda as questoes ligadas a epidemia da AIDS. Retraça sua origem, seu impacto sobre a sociedade, da maneira como modificou a relaçäo médico-paciente e de sua disseminaçäo pelo mundo. Mostra uma história da aquisiçäo progressiva de conhecimento clínicos, que permitiu fazer um paralelo entre o percurso intracelular do vírus e as circunstâncias misteriosas da doença infecciosa (CPS)


Subject(s)
Humans , Acquired Immunodeficiency Syndrome , AIDS-Related Opportunistic Infections
SELECTION OF CITATIONS
SEARCH DETAIL
...